Radiosynthesis of 4-[(2-chloroethyl)(2-[11C]ethyl)amino]-phenoxycarbonyl-l-glutamic acid a half mustard prodrug as a potential probe for imaging antibody- and gene-directed enzyme prodrug therapy with positron emission tomography-Reference-Cited by-同舟云学术

Radiosynthesis of 4-[(2-chloroethyl)(2-[11C]ethyl)amino]-phenoxycarbonyl-l-glutamic acid a half mustard prodrug as a potential probe for imaging antibody- and gene-directed enzyme prodrug therapy with positron emission tomography

Published:2004-06 Issue:6 Volume:60 Page:825-834
ISSN:0969-8043
Container-title:Applied Radiation and Isotopes
language:en
Short-container-title:Applied Radiation and Isotopes

Author:

Malik Nazreen,Luthra Sajinder.K,Burke Phil,Price Patrica M,Aboagye Eric O,Latigo John,Zhao Yongjun,Brady Frank

Publisher

Elsevier BV

Subject

Radiation

Reference27 articles.

1. A cytotoxic agent can be generated selectively at cancer sites;Bagshawe;Br. J. Cancer,1988

2. A new class of cytotoxic DNA minor groove binders;Cozzi;Il Farmaco,2001

3. Novel phenyl nitrogen mustard and half-mustard derivatives of amidino-modified distamycin;Cozzi;Bioorg. Med. Chem. Lett.,1997

4. Novel phenyl nitrogen mustard and half-mustard derivatives of distamycin A;Cozzi;Bioorg. Med. Chem. Lett.,1997

5. Automated synthesis of carbon-11 ethanol and carbon-11 butanol for human studies using positron emission tomography;Del Fiore;J. Radioanal. Chem.,1986

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positron Emission Tomography Image-Guided Drug Delivery: Current Status and Future Perspectives;Molecular Pharmaceutics;2014-06-04

2. Tumor-specific activation of prodrugs: is there a role for nuclear medicine?;Nuclear Medicine Communications;2008-10

3. Radiosynthesis of [11C]ximelagatran via palladium catalyzed [11C]cyanation;Journal of Labelled Compounds and Radiopharmaceuticals;2008-01

4. Building on a 50-year legacy of the MRC Cyclotron Unit: the Hammersmith radiochemistry pioneering journey;Journal of Labelled Compounds and Radiopharmaceuticals;2007

5. Novel gene-directed enzyme prodrug therapies against prostate cancer;Expert Opinion on Investigational Drugs;2006-07-21